Medical Cannabis Evidence-Based Care: Endocannabinoid System Clinical Research and Cannabinoid Clinical Trials
Clinical Takeaway People experiencing a first episode of psychosis have measurable rates of criminal legal involvement both before and after entering treatment, with specific individual factors predicting who is at greatest risk. Early identification of…
Cannabis use patterns in first episode psychosis and schizophrenia: A scoping review and case series.
Cannabis use is associated with psychosis development and symptom relapse in persons with schizophrenia spectrum disorders (SCZ). As U.S. states legalize can...
Endocannabinoid System Research: First-Episode Psychosis
Clinical Takeaway People experiencing first-episode psychosis have elevated rates of criminal legal involvement, with certain factors like substance use and aggressive behavior identifiable as predictors at initial presentation. Understanding these…
Endocannabinoid System in First-Episode Psychosis Care
Clinical Takeaway People with first-episode psychosis have elevated rates of criminal legal involvement that are measurable at baseline and predictable using identifiable clinical and demographic factors. Early identification of individuals at higher…
Endocannabinoid System Research and Clinical Psychosis Care
Clinical Takeaway Clinical Takeaway People experiencing first-episode psychosis have measurable rates of criminal legal involvement that can be identified at baseline and tracked over treatment. Understanding which clinical and demographic factors…
Endocannabinoid System & Psychosis Risk: Clinical Evidence
Clinical Takeaway People experiencing a first episode of psychosis have measurable rates of criminal legal involvement both before and after diagnosis, and certain clinical and demographic factors can help predict who is at greatest risk. Early,…
Research Digest: 4 Recent Studies – April 09, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 4 of 4 most recent studies from our monitored feeds. CED Clinical Relevance #81 Research Authority…
Cannabis use patterns in first episode psychosis and schizophrenia: A scoping review and case series.
Cannabis use is associated with psychosis development and symptom relapse in persons with schizophrenia spectrum disorders (SCZ). As U.S. states legalize can...